{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-044968","form_type":"8-K","ticker":null,"cik":"0001652724","company_name":"Lucira Health, Inc.","filed_at":"2023-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.018928+00:00","generated_at":"2026-06-19T05:01:23.421992+00:00","sec_items":["1.03","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Lucira Health files Chapter 11 bankruptcy, plans sale of business","bullets":["Filed Chapter 11 in Delaware on Feb 22, 2023; intends to sell business under Section 363 of Bankruptcy Code.","Cash on hand ~$4.5M; no debtor-in-possession financing required; funds operations and sale process.","Four directors resigned (Tuff Yen, Alison McCauley, Sandra Gardiner, Steve Tablak) effective Feb 17; Michael Wyse appointed lead independent director at $25k/month.","Bankruptcy driven by lower COVID-19 test demand and delayed FDA EUA for COVID-19/Flu combo test.","Company cautions common stock holders may receive no distribution; trading highly speculative."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-044968","json":"https://secwatch.observer/filing/0001193125-23-044968.json","markdown":"https://secwatch.observer/filing/0001193125-23-044968.md","text":"https://secwatch.observer/filing/0001193125-23-044968.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652724/000119312523044968/0001193125-23-044968-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652724/000119312523044968/d642141d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T05:01:23.421992+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b69c89afdfbc417932d75bc21ff736070678fdc","claim":"Lucira Health, Inc. entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2023-02-22).","evidence_excerpt":"On February 22, 2023, Lucira Health, Inc. (the “Company”) filed a voluntary petition for relief under chapter 11 of title 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”).","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652724/000119312523044968/0001193125-23-044968-index.htm","confidence":0.9,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 11"},{"label":"Court","value":"United States Bankruptcy Court for the District of Delaware"},{"label":"Petition","value":"2023-02-22"}],"fact_type":"distress_event"},{"claim_id":"04577cb27f","claim":"Michael Wyse was appointed as Lead Independent Director at Lucira Health, Inc..","evidence_excerpt":"appointed Michael Wyse to fill the newly created vacancy and serve as lead independent director, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652724/000119312523044968/0001193125-23-044968-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Lead Independent Director"}],"fact_type":"executive_change"},{"claim_id":"0fcd169b5e","claim":"Alison McCauley resigned as Director at Lucira Health, Inc..","evidence_excerpt":"Tuff Yen, Alison McCauley, Sandra A. Gardiner, and Steve Tablak, each members of the Board of Directors of the Company (the “Board”), provided notice of their resignation","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652724/000119312523044968/0001193125-23-044968-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"18d546da95","claim":"Sandra A. Gardiner resigned as Director at Lucira Health, Inc..","evidence_excerpt":"Tuff Yen, Alison McCauley, Sandra A. Gardiner, and Steve Tablak, each members of the Board of Directors of the Company (the “Board”), provided notice of their resignation","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652724/000119312523044968/0001193125-23-044968-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3a307758da","claim":"Steve Tablak resigned as Director at Lucira Health, Inc..","evidence_excerpt":"Tuff Yen, Alison McCauley, Sandra A. Gardiner, and Steve Tablak, each members of the Board of Directors of the Company (the “Board”), provided notice of their resignation","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652724/000119312523044968/0001193125-23-044968-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c110f3acf8","claim":"Tuff Yen resigned as Director at Lucira Health, Inc..","evidence_excerpt":"Tuff Yen, Alison McCauley, Sandra A. Gardiner, and Steve Tablak, each members of the Board of Directors of the Company (the “Board”), provided notice of their resignation","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652724/000119312523044968/0001193125-23-044968-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}